LERCANIDIPINE IN PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION

Shoalimova Z.M., Maxmudova M.S.

dc.contributor.author	Shoalimova Z.M., Maxmudova M.S.
dc.date.accessioned	2024-01-16T07:50:01Z
dc.date.available	2024-01-16T07:50:01Z
dc.date.issued	2023
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/10300
dc.description.abstract	Thus, in patients with isolated middleaged and elderly systolic hypertension, antihypertensive monotherapy with lercanidipine has a comparable antihypertensive effect, leads to normalization of the daily blood pressure profile with the achievement of the target level of systolic blood pressure in 73.3 and 75% of patients, respectively.	en_US
dc.language.iso	en	en_US
dc.publisher	СБОРНИК ТЕЗИСОВ XIII МЕЖДУНАРОДНОГО КОНГРЕССА «КАРДИОЛОГИЯ НА ПЕРЕКРЕСТКЕ НАУК»	en_US
dc.subject	systolic hypertension, antihypertensive monotherapy, lercanidipine	en_US
dc.title	LERCANIDIPINE IN PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION	en_US
dc.type	Thesis	en_US